Point72 Hong Kong Ltd Lowers Position in Raven Industries, Inc. (NASDAQ:RAVN)

Point72 Hong Kong Ltd lessened its stake in Raven Industries, Inc. (NASDAQ:RAVN) by 33.1% during the 2nd quarter, HoldingsChannel reports. The firm owned 1,529 shares of the conglomerate’s stock after selling 756 shares during the quarter. Point72 Hong Kong Ltd’s holdings in Raven Industries were worth $33,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in RAVN. Thrivent Financial for Lutherans lifted its position in shares of Raven Industries by 62.6% during the 1st quarter. Thrivent Financial for Lutherans now owns 921,238 shares of the conglomerate’s stock valued at $19,558,000 after buying an additional 354,758 shares in the last quarter. Morgan Stanley lifted its position in shares of Raven Industries by 74.2% during the 1st quarter. Morgan Stanley now owns 778,405 shares of the conglomerate’s stock valued at $16,526,000 after buying an additional 331,458 shares

Read More

Continue Reading

Jim Ross Discusses Bobby Heenan’s “Outspoken” Nature In WWE Creative Meetings

During the Grilling JR Podcast, Jim Ross covered the career of Bobby “The Brain” Heenan. Throughout the show, Ross mentioned how Heenan and a couple other WWE Hall of Famers pushed to get him hired in 1993. He also said when he first got hired, having the role of replacing Gorilla Monsoon was one of the toughest things to experience because he was replacing one of the greatest announcers of all time.

“Bobby Heenan, Gorilla Monsoon, and Mean Gene [Okerlund] were the three talents that really embraced me coming to WWE in 93′,” Ross said. “They were the vast minority because I was still looked at as the voice of WCW, the enemy. When I had got to WWE in 93′, I had been in the business for 19 years. I wasn’t some new kid on the block.

“I was replacing one of the most beloved characters behind the scenes

Read More

Continue Reading

OliX Pharmaceuticals Presents New Data on Asymmetric siRNA Therapy at TIDES: Oligonucleotides …

SUWON, Korea, Sept. 15, 2020 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today presented a poster at the TIDES: Oligonucleotides and Peptide Therapeutics 2020 Virtual Conference. The presentation entitled, “Asymmetric siRNA Therapeutics by OliX Pharmaceuticals,” highlights OliX’ proprietary asiRNA platform technology along with the preclinical/clinical development of various programs.

The Company presented the clinical development status of OLX101A, a cell-penetrating asymmetric siRNA (cp-asiRNA) targeting hypertrophic and keloid scars. OliX also presented data on ophthalmic pipelines that demonstrate the efficacy of OLX301A, targeting wet and dry age-related macular degeneration (AMD) in rodents and non-human primate disease models. In addition, OLX301D, targeting subretinal fibrosis and wet AMD, showed efficacy in relevant animal models. The Company also showcased data for its GalNAc-asiRNA platform technology for the treatment of liver diseases.

The presentation can be found on TIDES website https://tidesus2020.eventfinity.co/directories/17271/attendee/284822387.

“This data further validates

Read More

Continue Reading

Point72 Asset Management L.P. Trims Holdings in Armstrong World Industries Inc (NYSE:AWI)

Point72 Asset Management L.P. trimmed its holdings in Armstrong World Industries Inc (NYSE:AWI) by 99.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,249 shares of the construction company’s stock after selling 167,451 shares during the period. Point72 Asset Management L.P.’s holdings in Armstrong World Industries were worth $97,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Kayne Anderson Rudnick Investment Management LLC purchased a new position in Armstrong World Industries in the 2nd quarter worth approximately $39,860,000. London Co. of Virginia boosted its position in shares of Armstrong World Industries by 22.4% during the first quarter. London Co. of Virginia now owns 2,213,775 shares of the construction company’s stock worth $175,818,000 after acquiring an additional 405,278 shares

Read More

Continue Reading

Walton Arts Center gets creative to help local musicians survive pandemic

Unique performance opportunities give musicians a chance to keep playing.

Fayetteville, Ark. (KNWA/KFTA) — Local musicians now have some extra help surviving the COVID-19 pandemic.

Zac Archuleta and his band Arkansauce had a big summer planned.

“We were booked out through this whole year,” he said.

All those shows are now canceled or postponed.

“We were actually two days into an east coast tour when we heard the news about everything shutting down so essentially just long enough to drive out there and drive straight back,” Archuleta said.

Those shows are how bands like Arkansauce make most of their money. So The Walton Arts Center started Hearts to Homes; an online variety show.

“The whole idea was to keep our audience engaged in the arts during this time period when

Read More

Continue Reading

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) – Return On Capital Employed Overview: Rigel Pharmaceuticals

Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q2 sales of $16.02 million. Earnings fell to a loss of $17.39 million, resulting in a 182.71% decrease from last quarter. In Q1, Rigel Pharmaceuticals earned $21.03 million, and total sales reached $55.76 million.

Why ROCE Is Significant

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed in a business. Changes in earnings and sales indicate shifts in a company’s ROCE. A higher ROCE is generally representative of successful growth in a company and is a sign of higher earnings per share for shareholders in the future. A low or negative ROCE suggests the opposite. In Q2, Rigel Pharmaceuticals posted an ROCE of -0.28%.

Keep in mind, while ROCE is a good measure of a company’s recent performance, it is not a highly reliable predictor of a company’s earnings or sales in the near future.

ROCE is an important

Read More

Continue Reading

927 Shares in Worthington Industries, Inc. (NYSE:WOR) Bought by Point72 Hong Kong Ltd

Point72 Hong Kong Ltd bought a new position in Worthington Industries, Inc. (NYSE:WOR) in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 927 shares of the industrial products company’s stock, valued at approximately $35,000.

A number of other hedge funds have also recently modified their holdings of the stock. Bank of America Corp DE raised its stake in Worthington Industries by 9.9% in the 2nd quarter. Bank of America Corp DE now owns 186,423 shares of the industrial products company’s stock worth $6,954,000 after acquiring an additional 16,785 shares during the last quarter. Stifel Financial Corp purchased a new position in Worthington Industries in the 2nd quarter worth $385,000. Cipher Capital LP purchased a new position in Worthington Industries in the 2nd quarter worth $694,000. Gyon Technologies Capital Management LP purchased a new position in Worthington Industries in the

Read More

Continue Reading

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)

LOS ANGELES, Sept. 17, 2020 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 2, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ: FENC) securities between February 11, 2020 and August 10, 2020, inclusive (the “Class Period”).

(PRNewsfoto/Glancy Prongay & Murray LLP)

If you suffered a loss on your Fennec investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/fennec-pharmaceuticals-inc/.You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On August 11, 2020, before the market opened, Fennec disclosed that it had received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) regarding

Read More

Continue Reading

Lodha, MP Birla Group firms file pleas before Calcutta HC division bench against single-bench order



a large clock tower in the background: In a setback for Lodhas, the Calcutta High Court last Friday restrained Lodha, the chairman of MP Birla Group, from holding any office in any of the entities of the group.


© Provided by The Financial Express
In a setback for Lodhas, the Calcutta High Court last Friday restrained Lodha, the chairman of MP Birla Group, from holding any office in any of the entities of the group.

Harsh Vardhan Lodha and MP Birla Group entities on Monday filed multiple applications before a division bench of the Calcutta High Court, challenging a single bench order which restrained him from holding any office in any of the entities of the MP Birla Group during pendency of the suit involving the contested will of late Priyamvada Devi Birla, the widow of MP Birla.

At least four applications were filed on Monday and more are to be filed before the hearing begins at the division bench later this week. In a setback for Lodhas, the Calcutta High Court last Friday restrained Lodha, the chairman of MP Birla Group, from holding any office in any

Read More

Continue Reading

First Republic Investment Management Inc. Buys 97 Shares of Cavco Industries, Inc. (NASDAQ:CVCO)

First Republic Investment Management Inc. boosted its position in shares of Cavco Industries, Inc. (NASDAQ:CVCO) by 6.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,667 shares of the construction company’s stock after purchasing an additional 97 shares during the period. First Republic Investment Management Inc.’s holdings in Cavco Industries were worth $321,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Wellington Management Group LLP lifted its holdings in Cavco Industries by 64.2% during the 1st quarter. Wellington Management Group LLP now owns 665,529 shares of the construction company’s stock worth $96,461,000 after buying an additional 260,320 shares in the last quarter. William Blair Investment Management LLC bought a new position in Cavco Industries in the first quarter valued at about

Read More

Continue Reading

Load More